Suppr超能文献

慢性系统性红斑狼疮中的性激素。与临床和生物学参数的相关性。

Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters.

作者信息

Muñoz J A, Gil A, López-Dupla J M, Vázquez J J, González-Gancedo P

机构信息

Department of Internal Medicine and Endocrinology Laboratory, Hospital La Paz, Madrid, Spain.

出版信息

Ann Med Interne (Paris). 1994;145(7):459-63.

PMID:7864512
Abstract

Sex hormones may play a major role in the pathogenesis and course of systemic lupus erythematosus (SLE). OBJECTIVE--To evaluate the immunoregulatory effect of gonadal steroids in SLE and their mechanisms of action, and to establish a correlation with the clinical and biological activity. DESIGN--Cross-sectional study of a cohort with SLE. SETTING--Outpatient SLE clinic. PATIENTS--27 patients with chronic SLE, 14 were fertile women, 8 postmenopausal women and 5 men. MEASUREMENT--Serum gonadotropins (FSH, LH), prolactin (PRL), progesterone (PG), testosterone (T), estradiol (E2) and total urinary estrogens (UE) were studied in SLE patients and in 35 healthy controls of similar age and sex. Blood and urine samples of several days of the study cycle were obtained for hormonal assay. RESULTS--An increased LH activity was observed in all groups of patients. There were no changes in serum T levels, but absence of steroid therapy increased their levels in fertile women. A decrease in E2 values in the fertile women was observed, but total UE was similar to those in controls. This suggests an alteration in intermediate estrogen metabolism. Men with SLE showed a higher levels in PG and UE than controls. Also, in both groups of women on steroid treatment, a decrease of PRL was observed compared to the controls. In the fertile women in luteal phase, there was a decrease in PG. In the fertile women with higher clinical activity in the midcycle phase, and those with higher biological activity in the luteal phase, a decrease in serum E2 was seen. CONCLUSIONS--Our results support the hypothesis that there is an alteration of intermediate metabolism of the estrogens and of the testosterone. As well, a lower production of PRL during steroid treatment, and a lower production of PG may be important contributing factors in immunomodulation of SLE. Mechanism for this action should be mediated through a stimulation of the gonadotropins as LH.

摘要

性激素可能在系统性红斑狼疮(SLE)的发病机制和病程中起主要作用。目的——评估性腺类固醇在SLE中的免疫调节作用及其作用机制,并建立与临床和生物学活性的相关性。设计——对SLE队列的横断面研究。地点——门诊SLE诊所。患者——27例慢性SLE患者,其中14例为育龄妇女,8例绝经后妇女,5例男性。测量——研究了SLE患者以及35名年龄和性别相似的健康对照者的血清促性腺激素(FSH、LH)、催乳素(PRL)、孕酮(PG)、睾酮(T)、雌二醇(E2)和总尿雌激素(UE)。在研究周期的几天内采集血液和尿液样本进行激素检测。结果——在所有患者组中均观察到LH活性增加。血清T水平无变化,但未接受类固醇治疗的育龄妇女T水平升高。观察到育龄妇女E2值降低,但总UE与对照组相似。这表明雌激素中间代谢存在改变。SLE男性患者的PG和UE水平高于对照组。此外,与对照组相比,两组接受类固醇治疗的女性PRL均降低。在黄体期的育龄妇女中,PG降低。在月经周期中期临床活性较高的育龄妇女以及黄体期生物学活性较高的育龄妇女中,血清E2降低。结论——我们的结果支持以下假设:雌激素和睾酮的中间代谢存在改变。同样,类固醇治疗期间PRL分泌减少以及PG分泌减少可能是SLE免疫调节的重要促成因素。这种作用的机制应通过刺激如LH等促性腺激素来介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验